Open-Label Placebo Sleep Study for Insomnia

Not Applicable

Completed

• Conditions: Insomnia; Mental Health - Other mental health disorders; Neurological - Other neurological disorders

• Registration Number: ACTRN12622000683730
• Lead Sponsor: The University of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-05-11
• Study Completion: 2022-10-07
• Last Update Posted: 24 April 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Inclusion criteria
To participate, individuals must:
1.Reported Insomnia Severity Index (ISI) score of >7.
2.Have ability to read/speak English.
3.Be 18 years and older.
4.Have Internet access, computer access and an active email address.

Exclusion Criteria

Exclusion Criteria
Participants will be excluded from the study if they:
1.Have irregular sleep schedules that prevent the ability to follow intervention recommendations including night shift work, bedtimes outside of 8pm-2am or awakenings outside of 4am-10am.
2.Have uncontrolled or certain medical conditions deemed to interfere with the study procedures or put the participant at undue risk. 3.Are pregnant.
4.Have current psychological treatment for insomnia.
5.Are currently taking medications that interfere with sleep e.g. Steroids, Dexedrine, Ritalin, Adderall, and Provigil.

Study & Design

• Study Type: Interventional
• Study Design: Not specified